Royalty Pharma Sub-Manager, LLC
Top Portfolio Positions
4 positions ·
$173,576,174 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| CYTK |
Cytokinetics Inc
Healthcare
|
980,392 | $64,617,636 | 37.23% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
2,388,150 | $47,500,303 | 27.37% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
3,846,154 | $36,615,386 | 21.09% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
2,936,507 | $24,842,849 | 14.31% |
Portfolio Trend
2 quarters · across all stocks
Holdings in BHVN
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,842,849 | 2,936,507 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,153,164 | 2,936,507 | Shares | Defined | 2026-04-01 | |
| No 13F history on record for this holder in this stock. | ||||||